The market demand for coconut oil, virgin coconut oil and neutraceuticals is growing in double digits, Coconut Development Board chairman T K Jose told reporters here.
"There is a need to tap this demand. These value added products are happening in countries like US and Japan. Why can't APCC collectively develop technologies and share," he said.
Steps are on to adopt tissue culture in coconut palms to enable rapid multiplying of planting material which will revolutionise production in all coconut producing countries, Jose said.
"Discussions have been held on how to expedite and accelerate research on adopting tissue culture in coconut palms," Jose said.
This would be a possibility only in 5-10 year period, he said, adding that the central government had offered a lead role.
The first clinical trials on coconut oil among heart patients were conducted in India and APCC wants it to be held in multi countries and on different ethnic communities.
Another clinical study on Neera has also been initiated, he added.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
